DL-Penicillamine

Research use only, not for human use.

The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.

The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. (In Vivo):DL-Penicillamine (25 mg/kg; i.p.; twice daily, for 5 days) has antidotal effects in thallotoxicosis rats when co-treated with Prussian blue (HY-106594A).

——

DL-Penicillamine (25 mg/kg; i.p.; twice daily, for 5 days) has antidotal effects in thallotoxicosis rats when co-treated with Prussian blue (HY-106594A). Animal Model:Male Wistar rats, NIH strain (intoxicated by i.p. injection of 32 mg/kg thallium (I) acetate)Dosage:25 mg/kg Administration:i.p.; twice daily, for 5 daysResult:Decreased slightly the thallium content in blood, organs and brain.Increased the probability survival when co-treated with Prussian blue (50 mg/kg; p.o.).

——

Others

Other Targets

Others

——

——

52-66-4

149.21

C5H11NO2S

>98% (HPLC)

Free soluble in Water

CC(C)(S)C(N)C(O)=O

——

(-20℃)

With Ice Pack

≥ 2 years